Immunoadjuvant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20060008478A1
SERIAL NO

10510708

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An immunoadjuvant which can efficiently exhibit potent adjuvant activity and avoid conditions undesirable for living bodies, and comprises precipitates formed by coacervation of (a) a soluble protein (provided that a soluble protein contained in tuberculin is excluded), and (b) a mucopolysaccharide, and further comprises (c) a soluble protein contained in tuberculin wherein said (c) is coprecipitated with the precipitates.

First Claim

See full text

Other Claims data not available

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
RIKEN2-1 HIROSAWA WAKO-SHI SAITAMA 3510198 ?3510198
CELL-MEDICINE INC2-1-6 SENGEN TSUKUBA-SHI IBARAKI 305-0047

International Classification(s)

loading....
  • 2003 Application Filing Year
  • A61K Class
  • 10715 Applications Filed
  • 3418 Patents Issued To-Date
  • 31.90 % Issued To-Date
Click to zoom InYear of Issuance% of Matters IssuedCumulative IssuancesYearly Issuances20032004200520062007200820092010201120122013201420152016201720182019202020210255075100

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Huang, Lan Philadelphia, PA 88 535
Kuang, Ming Guangzhou, CN 34 636
Ohno, Tadao Ibaraki, JP 11 46
Uchimura, Eiji Ibaraki, JP 3 9

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 2 Citation Count
  • A61K Class
  • 9.53 % this patent is cited more than
  • 19 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges35920026843311538244232517103801 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +01002003004005006007008009001000110012001300140015001600170018001900200021002200

Forward Cite Landscape

Load Citation